Global Pulmonary Administration Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pulmonary Administration Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Pulmonary drug delivery system is a drug delivery route that directly delivers drugs to the respiratory tract and lungs. It is mainly used to treat respiratory diseases, such as asthma, COPD and lung cancer. This method of administration has the advantages of rapid onset, good efficacy, and reduced adverse reactions.

According to our (Global Info Research) latest study, the global Pulmonary Administration market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Pulmonary Administration market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Pulmonary Administration market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Pulmonary Administration market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Pulmonary Administration market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030

Global Pulmonary Administration market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pulmonary Administration

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pulmonary Administration market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aptar Pharma, Nemera, Porex, Chiesi Farmaceutici, AstraZeneca, H&T Presspart, Gerresheimer, Merxin Ltd, 3M, Aerogen Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Pulmonary Administration market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Pressurized Metered Dose Inhalation System
Dry Powder Inhalation System
Soft Mist Inhalation System
Others

Market segment by Application
Bronchial Asthma
Chronic Obstructive Pulmonary Disease
Others

Major players covered
Aptar Pharma
Nemera
Porex
Chiesi Farmaceutici
AstraZeneca
H&T Presspart
Gerresheimer
Merxin Ltd
3M
Aerogen Pharma
MedPharm
Kindeva Drug Delivery
Boehringer Ingelheim
Chiesi Farmaceutici SpA
Merck & Co, Inc
Novartis AG
PARI international
Vectura Group Plc
GlaxoSmithKline
Koninklijke Philips NV
OMRON Corporation
Sunovion Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Yisuo Intelligent

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pulmonary Administration product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Pulmonary Administration, with price, sales quantity, revenue, and global market share of Pulmonary Administration from 2019 to 2024.

Chapter 3, the Pulmonary Administration competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pulmonary Administration breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Pulmonary Administration market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Administration.

Chapter 14 and 15, to describe Pulmonary Administration sales channel, distributors, customers, research findings and conclusion.